Related Experiment Video
Updated: Feb 8, 2026

Monitoring Hippo Signaling Pathway Activity Using a Luciferase-based Large Tumor Suppressor LATS Biosensor
Published on: September 13, 2018
Assembly and activation of the Hippo signalome by FAT1 tumor suppressor
Daniel Martin1, Maria S Degese1, Lynn Vitale-Cross1
1Oral and Pharyngeal Cancer Branch, National Institutes of Health, Bethesda, MD 20892, USA.
Abstract:
Dysregulation of the Hippo signaling pathway and the consequent YAP1 activation is a frequent event in human malignancies, yet the underlying molecular mechanisms are still poorly understood. A pancancer analysis of core Hippo kinases and their candidate regulating molecules revealed few alterations in the canonical Hippo pathway, but very frequent genetic alterations in the FAT family of atypical cadherins. By focusing on head and neck squamous cell carcinoma (HNSCC), which displays frequent FAT1 alterations (29.8%), we provide evidence that FAT1 functional loss results in YAP1 activation. Mechanistically, we found that FAT1 assembles a multimeric Hippo signaling complex (signalome), resulting in activation of core Hippo kinases by TAOKs and consequent YAP1 inactivation. We also show that unrestrained YAP1 acts as an oncogenic driver in HNSCC, and that targeting YAP1 may represent an attractive precision therapeutic option for cancers harboring genomic alterations in the FAT1 tumor suppressor genes.
Insights
Loss of FAT1 function in head and neck squamous cell carcinoma (HNSCC) activates YAP1. This discovery reveals FAT1
Area of Science:
- Oncology
- Molecular Biology
- Cell Signaling
Background:
- The Hippo signaling pathway regulates organ size and is frequently dysregulated in cancer.
- YAP1 activation, a consequence of Hippo pathway dysregulation, drives tumorigenesis.
- Molecular mechanisms linking Hippo pathway alterations to cancer remain incompletely understood.
Purpose of the Study:
- To investigate the role of FAT1 in Hippo signaling and YAP1 activation in human malignancies.
- To elucidate the functional consequences of FAT1 alterations in head and neck squamous cell carcinoma (HNSCC).
- To explore YAP1 as a potential therapeutic target in FAT1-altered cancers.
Main Methods:
- Pancancer analysis of Hippo pathway kinases and regulatory molecules.
- Focus on genetic alterations in the FAT family, particularly FAT1, in HNSCC.
- Functional studies to link FAT1 loss to YAP1 activation and oncogenic functions.
Main Results:
- Few alterations found in canonical Hippo pathway components across cancers.
- Frequent genetic alterations identified in FAT atypical cadherins.
- FAT1 functional loss in HNSCC leads to YAP1 activation.
- FAT1 assembles a Hippo signaling complex, activating TAOKs and inactivating YAP1.
- Unrestrained YAP1 drives HNSCC oncogenesis.
Conclusions:
- FAT1 acts as a tumor suppressor by maintaining Hippo pathway integrity.
- YAP1 is a critical oncogenic driver in HNSCC with FAT1 alterations.
- Targeting YAP1 offers a potential precision therapeutic strategy for FAT1-mutated cancers.
More Related Videos
14:15Preparation of Myeloid Derived Suppressor Cells MDSC from Naive and Pancreatic Tumor-bearing Mice using Flow Cytometry and Automated Magnetic Activated Cell Sorting AutoMACS
Published on: June 18, 2012
07:44Non-Invasive Ultrasound Assessment of Endometrial Cancer Progression in Pax8-Directed Deletion of the Tumor Suppressors Arid1a and Pten in Mice
Published on: February 17, 2023
Related Concept Videos
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Protein Complex Assembly
Many viruses self-assemble into a fully functional unit using the infected host cell to...
Spindle Assembly
In most cells, centrosomes are the primary microtubule nucleation centers. In the centrosome-mediated pathway, the G2-prophase transition triggers centrosome maturation and increased microtubule nucleation. Progressive nucleation results in a...
Oligosaccharide Assembly
Multiple sugar molecules that may or may...
Assembly of Cytoskeletal Filaments